CEO Andrea Pfeifer talks about AC Immune’s roadmap to successful therapies in neurodegenerative diseases

May 3, 2019
PDF Version

AC Immune CEO Andrea Pfeifer outlines why AC Immune still believes that Abeta plays a major role in Alzheimer’s disease and how strategies for developing successful therapeutic interventions are shifting.

Read the full article in English